Hitchwood Capital Management LP Guardant Health, Inc. Transaction History

Hitchwood Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $15.4 Million - $32.2 Million	-320,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $3.81 Million - $5.37 Million	-30,000 Reduced 8.57%	320,000 $48.8 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $5 Million - $6.8 Million	50,000 Added 16.67%	350,000 $45.1 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $2.01 Million - $2.8 Million	25,000 Added 9.09%	300,000 $33.5 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $8.77 Million - $14.1 Million	145,000 Added 111.54%	275,000 $22.3 Million

Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $5.9 Million - $8.88 Million	-100,000 Reduced 43.48%	130,000 $9.05 Million
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $10.1 Million - $14.1 Million	-170,000 Reduced 42.5%	230,000 $18 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $12.2 Million - $21.5 Million	-195,000 Reduced 32.77%	400,000 $25.5 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $29.7 Million - $42.4 Million	465,000 Added 357.69%	595,000 $51.4 Million
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $4.46 Million - $12.7 Million	130,000 New	130,000 $9.97 Million

309

110M

2.51M

1.7M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.95B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Hitchwood Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hitchwood Capital Management LP with notifications on news.